Company

MabSpace Biosciences Co., Ltd.

MabSpace Biosciences Co., Ltd. develops antibody drugs and diagnostic reagents in Suzhou, China.

About

Founded in 2013 and based in Suzhou, China, MabSpace Biosciences Co., Ltd. develops antibody-based therapeutics for cancer and for fibrotic disorders of the lung, kidney and liver, using immune tolerance breaking technology (IMBT), along with diagnostic reagents. In 2019 it merged with Transcenta Holding Ltd. and became a subsidiary brand of that company. The listed stage is Series B.

2Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in